Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4,659 | $4,659 | $4,642 | $4,418 |
| - Cash | $577 | $766 | $898 | $1,042 |
| + Debt | $3,744 | $3,744 | $3,744 | $3,744 |
| Enterprise Value | $7,825 | $7,637 | $7,488 | $7,119 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$255 | -$118 | -$116 | -$255 |
| % Margin | – | – | – | – |
| EBITDA | -$157 | -$290 | -$276 | -$270 |
| % Margin | – | – | – | – |
| Net Income | -$255 | -$545 | -$530 | -$525 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.038 | -0.082 | -0.08 | -0.089 |
| % Growth | 53.2% | -2.4% | 10.2% | – |
| Operating Cash Flow | -$188 | -$132 | -$145 | -$176 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$188 | -$132 | -$145 | -$176 |